LLY vs. HIMS
LLY (Eli Lilly and Company) and HIMS (Hims & Hers Health, Inc.) are both stocks. Both are in the Healthcare sector — LLY in Drug Manufacturers - General, HIMS in Drug Manufacturers - Specialty & Generic. Over the past 5 years, LLY returned 36.02%/yr vs 31.17%/yr for HIMS. Their 0.11 correlation means their historical movements had little consistent relationship.
Performance
LLY vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LLY achieves a 9.23% return, which is significantly higher than HIMS's -2.53% return.
LLY
- 1D
- 4.86%
- 1M
- -2.52%
- 6M
- 6.03%
- YTD
- 9.23%
- 1Y
- 53.81%
- 3Y*
- 38.53%
- 5Y*
- 36.02%
- 10Y*
- 32.64%
- ALL TIME*
- 16.08%
HIMS
- 1D
- -1.59%
- 1M
- -17.32%
- 6M
- 29.71%
- YTD
- -2.53%
- 1Y
- -42.99%
- 3Y*
- 57.18%
- 5Y*
- 31.17%
- 10Y*
- —
- ALL TIME*
- 18.57%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $536.71M | $447.14M | $553.51M | |
| $3.42B | $3.10B | $3.43B |
LLY vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 9.23% | 40.25% | 33.30% | 60.91% | 34.26% | 66.08% | 31.04% | 18.58% |
HIMS Hims & Hers Health, Inc. | -2.53% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
Correlation
The correlation between LLY and HIMS is 0.01, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.01 |
Correlation (3Y) Balances recent behavior with more history. | 0.12 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.13 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.11 |
The correlation between LLY and HIMS shifts across timeframes, from 0.01 (1 year) to 0.13 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
LLY:
$1.10T
HIMS:
$7.06B
LLY:
$29.79
HIMS:
-$0.05
LLY:
13.17
HIMS:
3.23
LLY:
30.86
HIMS:
16.20
LLY:
$79.67B
HIMS:
$2.37B
LLY:
$66.93B
HIMS:
$1.70B
LLY:
$35.21B
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LLY vs. HIMS — Risk / Return Rank
LLY
HIMS
LLY vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LLY | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.87 | ||
| Sortino ratioReturn per unit of downside risk | +2.30 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 0.97 | +0.30 |
| Calmar ratioReturn relative to maximum drawdown | 2.33 | -0.56 | +2.89 |
| Martin ratioReturn relative to average drawdown | 6.43 | -0.89 | +7.32 |
Loading charts...
Drawdowns
LLY vs. HIMS - Drawdown Comparison
The maximum LLY drawdown since its inception was -68.24%, smaller than the maximum HIMS drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for LLY and HIMS.
Loading charts...
Drawdown Indicators
| LLY | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.24% | -87.29% | +19.05% |
Max Drawdown (1Y)Largest decline over 1 year | -23.18% | -76.86% | +53.68% |
Max Drawdown (3Y)Largest decline over 3 years | -34.48% | -78.88% | +44.40% |
Max Drawdown (5Y)Largest decline over 5 years | -34.48% | -78.88% | +44.40% |
Max Drawdown (10Y)Largest decline over 10 years | -34.48% | — | — |
Current DrawdownCurrent decline from peak | -5.32% | -53.96% | +48.64% |
Average DrawdownAverage peak-to-trough decline | -19.17% | -43.42% | +24.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.57% | 48.36% | -39.79% |
Volatility
LLY vs. HIMS - Volatility Comparison
The current volatility for Eli Lilly and Company (LLY) is 9.71%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 31.01%. This indicates that LLY experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LLY | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.71% | 31.01% | -21.30% |
Volatility (6M)Calculated over the trailing 6-month period | 27.87% | 74.25% | -46.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.53% | 92.44% | -53.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.68% | 84.26% | -51.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.42% | 77.67% | -47.25% |
Dividends
LLY vs. HIMS - Dividend Comparison
LLY's dividend yield for the trailing twelve months is around 0.55%, while HIMS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIMS Hims & Hers Health, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.55% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
Financials
LLY vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Eli Lilly and Company and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LLY vs. HIMS - Profitability Comparison
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Eli Lilly and Company reported a gross profit of 19.71B and revenue of 22.97B. Therefore, the gross margin over that period was 85.8%.
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Eli Lilly and Company reported an operating income of 8.98B and revenue of 22.97B, resulting in an operating margin of 39.1%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Eli Lilly and Company reported a net income of 7.10B and revenue of 22.97B, resulting in a net margin of 30.9%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
Frequently Asked Questions
LLY and HIMS have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (31.01%) compared to LLY (9.71%). In terms of maximum drawdown, LLY dropped -68.24% vs HIMS's -87.29%.
LLY currently has the higher Sharpe Ratio (1.40 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LLY and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer